Stay updated on Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial page.

Latest updates to the Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.5%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check35 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check64 days agoChange DetectedThe page has updated the version number from v2.15.0 to v2.15.2 and removed an erratum reference for a study on Atezolizumab in hepatocellular carcinoma.SummaryDifference0.2%
- Check78 days agoChange DetectedThe webpage has been updated to include new drug treatments for solid tumors, specifically listing Gemcitabine, Leucovorin, Nab-Paclitaxel, Oxaliplatin, Capecitabine, and Cisplatin. Additionally, the revision number has changed from v2.14.4 to v2.15.0.SummaryDifference31%
- Check85 days agoChange DetectedThe web page has been updated from version v2.14.3 to v2.14.4.SummaryDifference0.0%
Stay in the know with updates to Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab With Bevacizumab in Solid Tumors Clinical Trial page.